Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Lung Cancer

  Free Subscription

Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 63 articles:
HTML format

Single Articles

    July 2022
    Editorial Comment: Lung-RADS-Looking Back to Move Forward.
    AJR Am J Roentgenol. 2022;219:65.

    June 2022
  2. BYRNE SC, Hammer MM
    Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Demonstrating Nodule Growth.
    AJR Am J Roentgenol. 2022 Jun 8. doi: 10.2214/AJR.22.27869.
    PubMed     Abstract available

    May 2022
  3. BERGMANN LL, Hobbs S
    Beyond the AJR: The Impact of Screening Population in Lung Cancer Overdiagnosis.
    AJR Am J Roentgenol. 2022 May 25. doi: 10.2214/AJR.22.27970.

  4. GIERADA DS, Pinsky PF
    Beyond the AJR: Larger and More Diverse Lung Cancer Screening Population Expected After Expansion of Recommended Eligibility Criteria by U.S. Preventive Services Task Force.
    AJR Am J Roentgenol. 2022 May 4:1. doi: 10.2214/AJR.21.27288.

    Percutaneous Lung Biopsy: Point-Fine-Needle Aspiration First.
    AJR Am J Roentgenol. 2022;218:794-795.

    Percutaneous Lung Biopsy: Counterpoint-Core Biopsy to Allow for Molecular and Histologic Subtyping.
    AJR Am J Roentgenol. 2022;218:796.

    April 2022
  7. TAHIR I, Marquardt JP, Mercaldo ND, Bourgouin PP, et al
    Utility of Noncancerous Chest CT Features for Predicting Overall Survival and Noncancer Death in Patients With Stage I Lung Cancer Treated With Stereotactic Body Radiotherapy.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27484.
    PubMed     Abstract available

  8. CHILES C, Osarogiagbon RU
    Beyond the AJR: To Expand the Population-Level Benefit of Lung Cancer Screening, Expand Access to Racially Diverse Populations.
    AJR Am J Roentgenol. 2022 Apr 6:1. doi: 10.2214/AJR.21.27032.

    Editorial Comment: Promising Role of Volume Doubling Time in Patients With Sarcoma Lung Metastasis.
    AJR Am J Roentgenol. 2022;218:633.

    March 2022
  10. SANDLER KL, Deppen SA
    Beyond the AJR: Disparities in Lung Cancer Screening Adherence Persist in the Veterans Health Administration.
    AJR Am J Roentgenol. 2022 Mar 2:1. doi: 10.2214/AJR.21.26852.

  11. BOURGOUIN PP, Wrobel MM, Mercaldo ND, Murphy MC, et al
    Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
    AJR Am J Roentgenol. 2022;218:494-504.
    PubMed     Abstract available

    February 2022
  12. ZAFAR N
    Utility of Flat-Bevel Tip Introducer Cannula for Local Pleural Anesthesia During Percutaneous CT-Guided Lung Biopsy.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.21.27306.

    January 2022
  13. MENDOZA DP, Petranovic M, Som A, Wu MY, et al
    Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
    AJR Am J Roentgenol. 2022 Jan 26. doi: 10.2214/AJR.21.27180.
    PubMed     Abstract available

    Editorial Comment: Evolving Indications for FDG PET/MRI in Lung Cancer.
    AJR Am J Roentgenol. 2022 Jan 5. doi: 10.2214/AJR.21.27246.

    December 2021
    Reporting of Clinical Stage for Lung Cancer: Point-Yes, Report an Overall TNM Stage.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.27203.

  16. PEREZ-JOHNSTON R, McDermott S
    Reporting of Clinical Stage For Lung Cancer: Counterpoint-We Are Not There Yet!
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.27188.

  17. OHNO Y, Yoshikawa T, Takenaka D, Koyama H, et al
    Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.26868.
    PubMed     Abstract available

    November 2021
  18. HAMMER MM, Byrne SC
    Cancer Risk in Nodules Detected at Follow-up Lung Cancer Screening CT.
    AJR Am J Roentgenol. 2021 Nov 10. doi: 10.2214/AJR.21.26927.
    PubMed     Abstract available

  19. AHN Y, Lee SM, Kim MS, Choi S, et al
    Volume Doubling Times of Pulmonary Metastases in Patients With Bone and Soft Tissue Sarcomas: Associations With Subsequent New Metastases and Survival After Metastasectomy.
    AJR Am J Roentgenol. 2021 Nov 3. doi: 10.2214/AJR.21.26859.
    PubMed     Abstract available

  20. WROBEL MM, Bourgouin PP, Kashani MA, Leppelmann KS, et al
    Active Versus Passive Thaw After Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis.
    AJR Am J Roentgenol. 2021;217:1153-1163.
    PubMed     Abstract available

    August 2021
  21. BARUAH D
    Editorial Comment: Diagnosing Mediastinal Lymph Node Involvement in Non Small Cell Lung Cancer Noninvasively With Advanced Imaging Markers-Are We There Yet?
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26661.

  22. STEFANIDIS K, Konstantelloy E, Yusuf G, Moser J, et al
    The Evolving Landscape of Lung Cancer Surgical Resection: An Update for Radiologists With Focus on Key Chest CT Findings.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26408.
    PubMed     Abstract available

  23. PARK R, Lee SM, Kim S, Park S, et al
    Learning Curve for CT-Guided Percutaneous Transthoracic Core Needle Biopsy: Retrospective Evaluation Among 17 Thoracic Imaging Fellows at a Tertiary Referral Hospital.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26346.
    PubMed     Abstract available

  24. DENNIE C, Dyer D, Goo JM, Revel MP, et al
    The Global Reading Room: A Likely Infectious Abnormality on Lung Cancer Screening CT.
    AJR Am J Roentgenol. 2021 Aug 4. doi: 10.2214/AJR.21.26617.
    PubMed     Abstract available

    July 2021
  25. NAGANO H, Takumi K, Nakajo M, Fukukura Y, et al
    Dual-Energy CT-Derived Electron Density for Diagnosing Metastatic Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: Comparison With Conventional CT and FDG PET/CT Findings.
    AJR Am J Roentgenol. 2021 Jul 28. doi: 10.2214/AJR.21.26208.
    PubMed     Abstract available

  26. THAPALIYA S, Gilligan LA, Brady SL, Anton CG, et al
    Comparison of 0.3-mSv CT to Standard-Dose CT for Detection of Lung Nodules in Children and Young Adults With Cancer.
    AJR Am J Roentgenol. 2021 Jul 7. doi: 10.2214/AJR.21.26183.
    PubMed     Abstract available

    June 2021
    Editorial Comment: New Insights Into the MRI Diagnosis of Brain Metastasis From Lung Cancer.
    AJR Am J Roentgenol. 2021 Jun 2. doi: 10.2214/AJR.21.26288.

  28. CHELALA L, Hossain R, Kazerooni EA, Christensen JD, et al
    Lung-RADS Version 1.1: Challenges and a Look Ahead, From the AJR Special Series on Radiology Reporting and Data Systems.
    AJR Am J Roentgenol. 2021;216:1411-1422.
    PubMed     Abstract available

  29. ARAUJO-FILHO JAB, Halpenny D, McQuade C, Puthoff G, et al
    Management of Pulmonary Nodules in Oncologic Patients: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2021;216:1423-1431.
    PubMed     Abstract available

    May 2021
  30. KIM M, Suh CH, Lee SM, Park JE, et al
    Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis.
    AJR Am J Roentgenol. 2021 May 26. doi: 10.2214/AJR.21.25787.
    PubMed     Abstract available

    Editorial Comment: Metabolic Tumor Volume on FDG PET/CT for Predicting Lymphovascular Invasion of Lung Cancer-Proceed With Caution.
    AJR Am J Roentgenol. 2021 May 19. doi: 10.2214/AJR.21.26193.

  32. KOO CW
    Editorial Comment: Lobectomy Versus Sublobar Resection-How Preoperative CT Features Can Tell You How Much to Resect in Stage IA Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2021 May 19. doi: 10.2214/AJR.21.26175.

  33. LI C, Tian Y, Shen Y, Wen B, et al
    Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2021 May 12. doi: 10.2214/AJR.21.25814.
    PubMed     Abstract available

  34. CHOE J, Kim MY, Yun JK, Lee GD, et al
    Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    AJR Am J Roentgenol. 2021 May 12. doi: 10.2214/AJR.21.25618.
    PubMed     Abstract available

  35. HAAS BM
    Editorial Comment: Report Extent of Consolidation and Pulmonary Artery Diameter in Patients With Interstitial Lung Disease Who Are Undergoing an Initial Evaluation of Lung Cancer.
    AJR Am J Roentgenol. 2021 May 5. doi: 10.2214/AJR.21.26099.

    April 2021
  36. OZAWA Y, Shibamoto Y, Hiroshima M, Nakagawa M, et al
    Preoperative CT Findings for Predicting Acute Exacerbation of Interstitial Pneumonia After Lung Cancer Surgery: A Multicenter Case-Control Study.
    AJR Am J Roentgenol. 2021 Apr 14. doi: 10.2214/AJR.21.25499.
    PubMed     Abstract available

  37. GAN JM, Kikano EG, Smith DA, Bui MT, et al
    Role of Key Guidelines in an Era of Precision Oncology: A Primer for the Radiologist.
    AJR Am J Roentgenol. 2021;216:1112-1125.
    PubMed     Abstract available

    March 2021
  38. FLORES EJ, Narayan AK
    Beyond the AJR: "Using prediction-models to reduce persistent racial/ethnic disparities in draft 2020 USPSTF lung-cancer screening guidelines".
    AJR Am J Roentgenol. 2021 Mar 24. doi: 10.2214/AJR.21.25877.

  39. CHO JY, Winant AJ, Sohn JH, Vargas SO, et al
    CT Features of Benign Intrapulmonary Lymph Nodes in Pediatric Patients With Known Extrapulmonary Solid Malignancy.
    AJR Am J Roentgenol. 2021 Mar 17:1-6. doi: 10.2214/AJR.20.23363.
    PubMed     Abstract available

  40. LEE GM, Stowell JT, Pope K, Carter BW, et al
    Lymphatic Pathways of the Thorax: Predictable Patterns of Spread.
    AJR Am J Roentgenol. 2021;216:649-658.
    PubMed     Abstract available

    January 2021
  41. SERAI SD, Rapp JB, States LJ, Andronikou S, et al
    Pediatric Lung MRI: Currently Available and Emerging Techniques.
    AJR Am J Roentgenol. 2021 Jan 21:1-10. doi: 10.2214/AJR.20.23104.
    PubMed     Abstract available

    Editorial Comment: Practical Considerations in the Application of Recommendations for Suspected Infectious and Inflammatory Lung Abnormalities on Lung Cancer Screening CT.
    AJR Am J Roentgenol. 2021 Jan 20. doi: 10.2214/AJR.21.25447.

  43. JI Y, Shao CC, Cui Y, Cui K, et al
    The Diagnostic Value of FDG PET/CT and Thin-Slice High-Resolution Chest CT in Pulmonary Intravascular Metastasis.
    AJR Am J Roentgenol. 2021 Jan 6:1-7. doi: 10.2214/AJR.20.23017.
    PubMed     Abstract available

    December 2020
  44. MENDOZA DP, Chintanapakdee W, Zhang EW, Gilman MD, et al
    Management and Outcomes of Suspected Infectious and Inflammatory Lung Abnormalities Identified on Lung Cancer Screening CT.
    AJR Am J Roentgenol. 2020 Dec 30. doi: 10.2214/AJR.20.25124.
    PubMed     Abstract available

  45. PATEL BN, Langlotz CP
    Beyond the AJR: "Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model".
    AJR Am J Roentgenol. 2020 Dec 23. doi: 10.2214/AJR.20.25334.

  46. SMITH DA, Radzinsky E, Tirumani SH, Guler E, et al
    Findings on Chest CT Performed in the Emergency Department in Patients on Immune Checkpoint Inhibitor Therapy: Single-Institution 8-Year Experience in 136 Patients.
    AJR Am J Roentgenol. 2020 Dec 9. doi: 10.2214/AJR.20.24758.
    PubMed     Abstract available

  47. BOLEN MA
    Editorial Comment on "Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis".
    AJR Am J Roentgenol. 2020 Dec 2. doi: 10.2214/AJR.20.24243.

  48. AHUJA J, Shroff GS, Benveniste MF, Marom EM, et al
    In Situ Pulmonary Artery Thrombosis: Unrecognized Complication of Radiation Therapy.
    AJR Am J Roentgenol. 2020;215:1329-1334.
    PubMed     Abstract available

    November 2020
  49. XUE Y, Chen D, Chen Y
    Reporting Accuracy in Prediction of Lymph Node Metastasis of Lung Adenocarcinoma With Radiomics.
    AJR Am J Roentgenol. 2020;215:W60.

    October 2020
  50. HATA A, Yanagawa M, Yoshida Y, Miyata T, et al
    Combination of Deep Learning-Based Denoising and Iterative Reconstruction for Ultra-Low-Dose CT of the Chest: Image Quality and Lung-RADS Evaluation.
    AJR Am J Roentgenol. 2020 Oct 14:1-8. doi: 10.2214/AJR.19.22680.
    PubMed     Abstract available

  51. LITTLE BP, Junn JC, Zheng KS, Sanchez FW, et al
    Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Imaging and Clinical Features of a Frequently Delayed Diagnosis.
    AJR Am J Roentgenol. 2020 Oct 6:1-9. doi: 10.2214/AJR.19.22628.
    PubMed     Abstract available

    September 2020
  52. OHNO Y, Takeshi Y, Takenaka D, Koyama H, et al
    Comparison of Diagnostic Accuracy for TNM Stage Among Whole-Body MRI and Coregistered PET/MRI Using 1.5-T and 3-T MRI Systems and Integrated PET/CT for Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2020 Sep 22:1-8. doi: 10.2214/AJR.19.22565.
    PubMed     Abstract available

    August 2020
  53. GRASPARIL AD 2ND, Gottumukkala RV, Greer MC, Gee MS, et al
    Whole-Body MRI Surveillance of Cancer Predisposition Syndromes: Current Best Practice Guidelines for Use, Performance, and Interpretation.
    AJR Am J Roentgenol. 2020 Aug 18:1-10. doi: 10.2214/AJR.19.22399.
    PubMed     Abstract available

    July 2020
  54. MENDOZA DP, Heeger A, Mino-Kenudson M, Lanuti M, et al
    Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23835.
    PubMed     Abstract available

  55. MORTANI BARBOSA EJ JR, Yang R, Hershman M
    Real World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    AJR Am J Roentgenol. 2020 Jul 15. doi: 10.2214/AJR.20.23637.
    PubMed     Abstract available

    June 2020
  56. LI Q, Li X, Li XY, Huo JW, et al
    Spectral CT in Lung Cancer: Usefulness of Iodine Concentration for Evaluation of Tumor Angiogenesis and Prognosis.
    AJR Am J Roentgenol. 2020 Jun 22:1-8. doi: 10.2214/AJR.19.22688.
    PubMed     Abstract available

  57. BANKS KP, Peacock JG, Gusman M, Clemenshaw MN, et al
    It's About Quality, Not Quantity: Qualitative FDG PET/CT Criteria for Therapy Response Assessment in Clinical Practice.
    AJR Am J Roentgenol. 2020 Jun 17:1-12. doi: 10.2214/AJR.19.22642.
    PubMed     Abstract available

    April 2020
  58. TAU N, Stundzia A, Yasufuku K, Hussey D, et al
    Convolutional Neural Networks in Predicting Nodal and Distant Metastatic Potential of Newly Diagnosed Non-Small Cell Lung Cancer on FDG PET Images.
    AJR Am J Roentgenol. 2020 Apr 29:1-6. doi: 10.2214/AJR.19.22346.
    PubMed     Abstract available

  59. CHU ZG, Li WJ, Fu BJ, Lv FJ, et al
    CT Characteristics for Predicting Invasiveness in Pulmonary Pure Ground-Glass Nodules.
    AJR Am J Roentgenol. 2020 Apr 29:1-8. doi: 10.2214/AJR.19.22381.
    PubMed     Abstract available

  60. SORENSEN L, Nielsen M, Petersen J, Pedersen JH, et al
    Chronic Obstructive Pulmonary Disease Quantification Using CT Texture Analysis and Densitometry: Results From the Danish Lung Cancer Screening Trial.
    AJR Am J Roentgenol. 2020 Apr 7:1-11. doi: 10.2214/AJR.19.22300.
    PubMed     Abstract available

    January 2020
  61. ONISHI Y, Kusumoto M, Motoi N, Watanabe H, et al
    Ciliated Muconodular Papillary Tumor of the Lung: Thin-Section CT Findings of 16 Cases.
    AJR Am J Roentgenol. 2020 Jan 22:1-5. doi: 10.2214/AJR.19.21945.
    PubMed     Abstract available

    December 2019
  62. SUH YJ, Park CM, Han K, Jeon SK, et al
    Utility of FDG PET/CT for Preoperative Staging of Non-Small Cell Lung Cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller.
    AJR Am J Roentgenol. 2019 Dec 17:1-9. doi: 10.2214/AJR.19.21811.
    PubMed     Abstract available

    November 2019
  63. SHAO X, Niu R, Jiang Z, Shao X, et al
    Role of PET/CT in Management of Early Lung Adenocarcinoma.
    AJR Am J Roentgenol. 2019 Nov 12:1-9. doi: 10.2214/AJR.19.21585.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.